Table 1.
Diagnostic tools suggested for hepatitis B screening prior to immunosuppression therapy by different major guidelines
| Recommendations |
Hepatitis B screening tests before immunosuppression |
|||
| HBsAg | AntiHBc | HBV DNA | AntiHBs | |
| CDC | Yes | Yes | No | Yes |
| AASLD | High risk | High risk | No | No |
| EASL | Yes | Yes | No | No |
| APASL | Yes | No | No | No |
| ASCO | High risk | High risk | No | Yes1 |
1
Only suggested in antiHBc-positive patients. CDC: Center for Disease Control; AASLD: American Association for the Study of Liver Disease; EASL: European Association for the Study of the Liver; APASL: Asian Pacific Association for the Study of the Liver; ASCO: American Society Clinical Oncology; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; AntiHBc: Antibody to hepatitis B core antigen; AntiHBs: Antibody to hepatitis B surface antigen.